Drug Profile
Research programme: apoptosis stimulant - Curapel
Alternative Names: OlidexLatest Information Update: 15 Sep 2023
Price :
$50
*
At a glance
- Originator University of Manchester
- Developer Curapel
- Class Antipsoriatics
- Mechanism of Action Apoptosis stimulants; Cytokine inhibitors; Keratinocyte inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Plaque psoriasis
Most Recent Events
- 15 Sep 2023 Discontinued - Preclinical for Plaque psoriasis in United Kingdom (Topical) (Curapel website, September 2023)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Plaque-psoriasis in United Kingdom (Topical, Cream)